dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse

Author Topic: Using a gene editor like CRISPR to make temp edits without sequence changes +MOR  (Read 186 times)

Offline Chip (OP)

  • Server Admin
  • Hero Member
  • *****
  • Administrator
  • *****
  • Join Date: Dec 2014
  • Location: Australia
  • Posts: 6689
  • Reputation Power: 0
  • Chip has hidden their reputation power
  • Gender: Male
  • Last Login:November 30, 2024, 06:44:31 AM
  • Deeply Confused Learner
  • Profession: IT Engineer
By using Epigenetics and effecting changes in the Histone process, you can make resilient yet temporary changes to the Genome without alterations to the sequence !

First floated August 16, 2024:

See attached file and snapshot of file creation/update data:




The idea is rooted in an AI reply on gene methylation via Epigenetics:
See also:
Quote

Conversation opened. 1 read message.

Skip to content
Using Gmail with screen readers
Tumour histone

12 of 12
Disable HIV or any virus without DNA and Cancer too 👌

Andrew Egerszegi <aegersz@gmail.com>
Sun 22 Sept 2024, 12:13
to info, info, mediainquiries

To whom is your Immunologist,

I am writing to share an innovative therapeutic concept that I believe could be valuable in addressing some of the most challenging diseases today, including retroviruses, non-DNA viruses, and cancer.

The idea focuses on histone methylation mimicry, particularly targeting specific histone modifications to influence gene expression. This method could have significant potential in:

Suppressing viral reactivation in the context of retroviruses.

Inhibiting the proliferation of oncogenes in cancer cells.

Controlling gene expression to affect non-DNA viruses through epigenetic regulation.

By manipulating methylation at key histone sites (such as H3K4me and H3K27me), the strategy would allow for targeted repression or activation of genes, potentially offering a novel therapeutic route. The role of histone methylation in chromatin dynamics suggests it could be particularly effective in silencing harmful viral genes or oncogenic pathways without affecting the host genome broadly.

I believe this concept could be explored further by research teams focused on the epigenetic regulation of viruses and cancers !


Claim staked, 😆
« Last Edit: November 28, 2024, 03:22:34 AM by Chip »
friendly
0
funny
0
informative
0
agree
0
disagree
0
like
0
dislike
0
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
No reactions
Our Discord Server invitation link is https://discord.gg/jB2qmRrxyD

Tags:
 

Related Topics

  Subject / Started by Replies Last post
6 Replies
15864 Views
Last post November 04, 2015, 04:00:18 PM
by Jega
0 Replies
7198 Views
Last post June 02, 2018, 12:27:21 PM
by Chip
0 Replies
8053 Views
Last post May 10, 2019, 08:24:58 PM
by Chip
1 Replies
10492 Views
Last post September 23, 2021, 02:50:53 PM
by williamramirez
0 Replies
8124 Views
Last post July 09, 2019, 05:28:45 AM
by Chip
2 Replies
27775 Views
Last post November 09, 2019, 05:30:36 AM
by Chip
0 Replies
6624 Views
Last post October 29, 2019, 05:20:14 AM
by Chip
0 Replies
6998 Views
Last post November 21, 2019, 06:47:09 AM
by Chip
0 Replies
7539 Views
Last post June 28, 2023, 06:19:03 AM
by Chip
0 Replies
9832 Views
Last post August 16, 2023, 06:49:09 PM
by Chip


dopetalk does not endorse any advertised product nor does it accept any liability for it's use or misuse





TERMS AND CONDITIONS

In no event will d&u or any person involved in creating, producing, or distributing site information be liable for any direct, indirect, incidental, punitive, special or consequential damages arising out of the use of or inability to use d&u. You agree to indemnify and hold harmless d&u, its domain founders, sponsors, maintainers, server administrators, volunteers and contributors from and against all liability, claims, damages, costs and expenses, including legal fees, that arise directly or indirectly from the use of any part of the d&u site.


TO USE THIS WEBSITE YOU MUST AGREE TO THE TERMS AND CONDITIONS ABOVE


Founded December 2014
SimplePortal 2.3.6 © 2008-2014, SimplePortal